menu
    • menu

    Company profile for Dunad Therapeutics

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dunad’s unique small molecule platform induces targeted degradation of disease-causing proteins via direct modulation of the target protein’s surface topology. The Company’s novel molecular approach, based on mono-valent small molecules, is fully tuneable to be exquisitely selective for the target, and is underpinned by a target-class agnostic mechanism of action that is distinct from traditional mechanisms of targeted p...
    Dunad’s unique small molecule platform induces targeted degradation of disease-causing proteins via direct modulation of the target protein’s surface topology. The Company’s novel molecular approach, based on mono-valent small molecules, is fully tuneable to be exquisitely selective for the target, and is underpinned by a target-class agnostic mechanism of action that is distinct from traditional mechanisms of targeted protein degradation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Dunad Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    15th Floor 125 Old Broad Street, London EC2N 1AR
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.dunad.co.uk/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dunad Therapeutics Announces Appointment of Chief Business Officer
    Dunad Therapeutics Announces Appointment of Chief Business Officer

    08 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230808765192/en

    BUSINESSWIRE
    08 Aug 2023
    Share Share
    Dunad Therapeutics Announces Appointment of Chief R&D Officer
    Dunad Therapeutics Announces Appointment of Chief R&D Officer

    14 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220914005129/en

    BUSINESSWIRE
    14 Sep 2022
    Share Share
    Dunad Tx Appoints Industry Veteran Pearl Huang as Chief Executive Officer
    Dunad Tx Appoints Industry Veteran Pearl Huang as Chief Executive Officer

    28 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220628005199/en

    BUSINESSWIRE
    28 Jun 2022
    Share Share
    Dalriada Drug Discovery Celebrates Client Dunad Billion Collab with Novartis
    Dalriada Drug Discovery Celebrates Client Dunad Billion Collab with Novartis

    04 Nov 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/dalriada-drug-discovery-celebrates-client-dunad-therapeutics-billion-dollar-collaboration-with-novartis-301415922.html

    PRNEWSWIRE
    04 Nov 2021
    Share Share
    Dunad Therapeutics and Novartis enter partnership to develop protein therapies
    Dunad Therapeutics and Novartis enter partnership to develop protein therapies

    01 Nov 2021

    // PHARMAFILE

    http://www.pharmafile.com/news/594017/dunad-therapeutics-and-novartis-enter-partnership-develop-protein-therapies

    PHARMAFILE
    01 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search